{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:07:20Z","timestamp":1771297640342,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1895,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The mechanisms underlying the beneficial effect of ferric carboxymaltose (FCM) in patients with heart failure (HF) and iron deficiency (ID) have not been completely characterized. The Myocardial-IRON trial was a double-blind, randomized trial that evaluated myocardial iron repletion following FCM vs. placebo in 53 patients with HF and ID. In this post hoc analysis, we evaluated whether treatment with FCM was associated with cardiac magnetic resonance changes in left and right ventricular function (LVEF and RVEF, respectively) at different points of systolic dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We included patients from the Myocardial-IRON trial with left and right ventricular systolic dysfunction (LVSD and RVSD, respectively) at enrolment. Linear mixed regression models were used to evaluate changes at 7 and 30 days on LVEF and RVEF at cardiac magnetic resonance. At enrolment, 27 (50.9%) and 38 (71.7%) patients had LVEF &amp;lt; 40% (LVSD1) or &amp;lt;45% (LVSD2), respectively, and 10 (18.9%) and 17 (32.1%) patients had RVEF &amp;lt; 45% (RVSD1) or &amp;lt;51% in women and &amp;lt;52% in men (RVSD2), respectively. Treatment with FCM was associated with a significant improvement in LVEF at 30 days (LVSD1: \u03942.3%, P &amp;lt; 0.001; LVSD2: \u03944.1, P = 0.014). FCM was also associated with a significant and early improvement in RVEF at 7 days (RVSD1: \u03946.9%, P = 0.003; RVSD2: \u03943.2%, P = 0.003) that persisted at 30 days (RVSD1: \u03948.1%, P &amp;lt; 0.001; RVSD2: \u03944.7%, P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with HF and systolic dysfunction with ID, FCM was associated with short-term improvement in LVEF and, especially, in RVEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13053","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T05:30:36Z","timestamp":1602394236000},"page":"4222-4230","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Short-Term Changes in Left and Right Systolic Function Following Ferric Carboxymaltose: A Substudy of the Myocardial-IRON Trial"],"prefix":"10.1093","volume":"7","author":[{"given":"Enrique","family":"Santas","sequence":"first","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario de Valencia, Universidad de Valencia, INCLIVA , Valencia ,","place":["Spain"]},{"name":"CIBER Cardiovascular , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Mi\u00f1ana","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario de Valencia, Universidad de Valencia, INCLIVA , Valencia ,","place":["Spain"]},{"name":"CIBER Cardiovascular , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Cardells","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de Manises , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Palau","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario de Valencia, Universidad de Valencia, INCLIVA , Valencia ,","place":["Spain"]},{"name":"CIBER Cardiovascular , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Ll\u00e0cer","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital Universitario Ram\u00f3n y Cajal , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"F\u00e1cila","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital General Universitario de Valencia , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Almenar","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Universitario La Fe de Valencia , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P.","family":"L\u00f3pez-Lereu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Unit, ERESA-Ascires Biomedical Group , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose V.","family":"Monmeneu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Unit, ERESA-Ascires Biomedical Group , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Sanchis","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario de Valencia, Universidad de Valencia, INCLIVA , Valencia ,","place":["Spain"]},{"name":"CIBER Cardiovascular , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia M.","family":"Maceira","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Unit, ERESA-Ascires Biomedical Group , Valencia ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Bay\u00e9s-Gen\u00eds","sequence":"additional","affiliation":[{"name":"CIBER Cardiovascular , Madrid ,","place":["Spain"]},{"name":"Cardiology Department and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico Universitario de Valencia, Universidad de Valencia, INCLIVA , Valencia ,","place":["Spain"]},{"name":"CIBER Cardiovascular , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Myocardial-IRON Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,11]]},"reference":[{"key":"2026012115031463100_ehf213053-bib-0001","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012115031463100_ehf213053-bib-0002","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ejhf.1305","article-title":"Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice","volume":"20","author":"McDonagh","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0003","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ejhf.513","article-title":"Iron deficiency and risk of early readmission following a hospitalization for acute heart failure","volume":"18","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0004","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0005","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012115031463100_ehf213053-bib-0006","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012115031463100_ehf213053-bib-0007","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ejhf.1434","article-title":"Intravenous iron therapy in heart failure: a different perspective","volume":"21","author":"Ghafourian","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0008","first-page":"300","article-title":"Iron and heart failure","volume":"5","author":"Ghafourian","year":"2020","journal-title":"J Am Coll Cardiol Basic Trans Science"},{"key":"2026012115031463100_ehf213053-bib-0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10741-018-9738-4","article-title":"Structural and functional abnormalities in iron-depleted heart","volume":"24","author":"Kobak","year":"2019","journal-title":"Heart Fail Rev"},{"key":"2026012115031463100_ehf213053-bib-0010","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0011","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetic in patients with chronic heart failure and iron deficiency: FERRIC II randomized mechanistic trial","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"2026012115031463100_ehf213053-bib-0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014254","article-title":"Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the Myocardial-IRON trial","volume":"9","author":"Nu\u00f1ez","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026012115031463100_ehf213053-bib-0013","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2016.03.039","article-title":"Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative\/nitrosative stress and inflammation","volume":"212","author":"Toblli","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012115031463100_ehf213053-bib-0014","first-page":"236","article-title":"Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency","volume":"21","author":"Usmanov","year":"2008","journal-title":"J Nephrol"},{"key":"2026012115031463100_ehf213053-bib-0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1540-8175.2011.01532.x","article-title":"Tissue Doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy","volume":"29","author":"Gaber","year":"2012","journal-title":"Echocardiography"},{"key":"2026012115031463100_ehf213053-bib-0016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/clc.22956","article-title":"Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): study design","volume":"41","author":"Mi\u00f1ana","year":"2018","journal-title":"Clin Cardiol"},{"key":"2026012115031463100_ehf213053-bib-0017","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jez232","article-title":"European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity","volume":"20","author":"Petersen","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012115031463100_ehf213053-bib-0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-019-09815-z","article-title":"Iron deficiency as therapeutic target in heart failure: a translational approach","volume":"25","author":"Bakogiannis","year":"2019","journal-title":"Heart Fail Rev"},{"key":"2026012115031463100_ehf213053-bib-0019","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowka","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2019.02.018","article-title":"Iron supplementation improves cardiovascular outcomes in patients with heart failure","volume":"132","author":"Zhou","year":"2019","journal-title":"Am J Med"},{"key":"2026012115031463100_ehf213053-bib-0021","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.hlc.2014.12.161","article-title":"Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron","volume":"24","author":"Toblli","year":"2015","journal-title":"Heart Lung Circ"},{"key":"2026012115031463100_ehf213053-bib-0022","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ehf2.12101","article-title":"Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study","volume":"3","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0023","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/ehf2.12503","article-title":"Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy","volume":"6","author":"Martens","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0024","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2026012115031463100_ehf213053-bib-0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","article-title":"Myocardial iron homeostasis in advanced chronic heart failure patients","volume":"159","author":"Lescek","year":"2012","journal-title":"Int J Cardiol"},{"key":"2026012115031463100_ehf213053-bib-0026","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/08880018.2012.763077","article-title":"Iron deficiency anemia in infants: does it really affect the myocardial functions?","volume":"30","author":"Alioglu","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"2026012115031463100_ehf213053-bib-0027","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/CIRCRESAHA.116.305265","article-title":"Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat","volume":"116","author":"Cotroneo","year":"2015","journal-title":"Circ Res"},{"key":"2026012115031463100_ehf213053-bib-0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.01.016","article-title":"Effects of darbepoetin \u03b1 on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"155","author":"Parissis","year":"2008","journal-title":"Am Heart J"},{"key":"2026012115031463100_ehf213053-bib-0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ehf2.12462","article-title":"Effect of ferric carboxymaltose on calculated plasma volumen status and clinical congestion: a FAIR-HF substudy","volume":"6","author":"Okonko","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2026012115031463100_ehf213053-bib-0030","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1053\/euhj.2000.2011","article-title":"Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are the interchangeable?","volume":"21","author":"Bellenger","year":"2000","journal-title":"Eur Heart J"},{"key":"2026012115031463100_ehf213053-bib-0031","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.echo.2007.01.038","article-title":"Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance","volume":"20","author":"Wang","year":"2007","journal-title":"J Am Soc Echocardiogr"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/6\/4222\/65902390\/eschf_7_6_4222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/6\/4222\/65902390\/eschf_7_6_4222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:03:49Z","timestamp":1769025829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/6\/4222\/8372515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,11]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,10,11]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13053","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,10,11]]},"assertion":[{"value":"2020-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}